Hydrodynamic delivery protocols
- PMID: 20217552
- DOI: 10.1007/978-1-60761-588-0_12
Hydrodynamic delivery protocols
Abstract
RNA interference (RNAi) holds considerable promise as a novel therapeutic strategy to silence disease-causing genes not amenable to conventional therapeutics. Since it relies on small interfering RNAs (siRNAs), which are the mediators of RNAi-induced specific mRNA degradation, a major issue is the delivery of therapeutically active siRNAs into the target tissue. In vivo gene silencing with RNAi has been reported using both viral vector delivery and high-pressure, high-volume intravenous (i.v.) injection of synthetic siRNAs. For safety reasons, strategies based on viral vector delivery may be only of limited clinical use. The more desirable approach is to directly deliver active siRNAs. We describe the use of hydrodynamic administration as a technique to deliver naked siRNA constructs into experimental animals as a method of transient gene knockdown. This approach demonstrates that RNAi can be used to silence endogenous genes, involved in the cause of human diseases, with a clinically acceptable formulation and route of administration.
Similar articles
-
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18. J Biotechnol. 2006. PMID: 16413079 Review.
-
Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.Gene Ther. 2008 Aug;15(15):1126-30. doi: 10.1038/gt.2008.24. Epub 2008 Mar 6. Gene Ther. 2008. PMID: 18323791
-
Nonviral in vivo delivery of therapeutic small interfering RNAs.Curr Opin Mol Ther. 2007 Aug;9(4):345-52. Curr Opin Mol Ther. 2007. PMID: 17694447 Review.
-
Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.Early Hum Dev. 2009 Oct;85(10 Suppl):S31-5. doi: 10.1016/j.earlhumdev.2009.08.013. Epub 2009 Oct 14. Early Hum Dev. 2009. PMID: 19833462
-
Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection.Methods Enzymol. 2005;392:336-50. doi: 10.1016/S0076-6879(04)92020-4. Methods Enzymol. 2005. PMID: 15644191
Cited by
-
In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosis.Atherosclerosis. 2011 Mar;215(1):34-42. doi: 10.1016/j.atherosclerosis.2010.07.057. Epub 2010 Aug 10. Atherosclerosis. 2011. PMID: 20810113 Free PMC article.
-
Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA.Int J Med Sci. 2013 Jun 9;10(8):957-64. doi: 10.7150/ijms.5632. Print 2013. Int J Med Sci. 2013. PMID: 23801881 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources